Matches in SemOpenAlex for { <https://semopenalex.org/work/W2670503891> ?p ?o ?g. }
- W2670503891 endingPage "e0179156" @default.
- W2670503891 startingPage "e0179156" @default.
- W2670503891 abstract "Kisspeptins (KPs) and their receptor (GPR54 or KiSS1R) play a key-role in regulation of the hypothalamic-pituitary-gonadal axis and are therefore interesting targets for therapeutic interventions in the field of reproductive endocrinology. As dogs show a rapid and robust LH response after the administration of KP10, they can serve as a good animal model for research concerning KP signaling. The aims of the present study were to test the antagonistic properties of KP analogs p234, p271, p354, and p356 in vitro, by determining the intracellular Ca2+ response of CHEM1 cells that stably express human GPR54, and to study the in vivo effects of these peptides on basal plasma LH concentration and the KP10-induced LH response in female dogs. Exposure of the CHEM1 cells to KP-10 resulted in a clear Ca2+ response. P234, p271, p354, and p356 did not prevent or lower the KP10-induced Ca2+ response. Moreover, the in vivo studies in the dogs showed that none of these supposed antagonists lowered the basal plasma LH concentration and none of the peptides lowered the KP10-induced LH response. In conclusion, p234, p271, p354, and p356 had no antagonistic effects in vitro nor any effect on basal and kisspeptin-stimulated plasma LH concentration in female dogs." @default.
- W2670503891 created "2017-06-30" @default.
- W2670503891 creator A5002342549 @default.
- W2670503891 creator A5015876453 @default.
- W2670503891 creator A5016039667 @default.
- W2670503891 creator A5045206039 @default.
- W2670503891 creator A5047483416 @default.
- W2670503891 creator A5051385271 @default.
- W2670503891 creator A5056031868 @default.
- W2670503891 creator A5057713605 @default.
- W2670503891 creator A5071985251 @default.
- W2670503891 creator A5075153538 @default.
- W2670503891 creator A5078949048 @default.
- W2670503891 date "2017-06-26" @default.
- W2670503891 modified "2023-10-17" @default.
- W2670503891 title "In vitro and in vivo effects of kisspeptin antagonists p234, p271, p354, and p356 on GPR54 activation" @default.
- W2670503891 cites W160383565 @default.
- W2670503891 cites W1906806616 @default.
- W2670503891 cites W1967138218 @default.
- W2670503891 cites W1972630529 @default.
- W2670503891 cites W1979536972 @default.
- W2670503891 cites W1982410791 @default.
- W2670503891 cites W1982432756 @default.
- W2670503891 cites W2006281604 @default.
- W2670503891 cites W2006727096 @default.
- W2670503891 cites W2012579732 @default.
- W2670503891 cites W2013104189 @default.
- W2670503891 cites W2027421516 @default.
- W2670503891 cites W2032263844 @default.
- W2670503891 cites W2040905954 @default.
- W2670503891 cites W2046411043 @default.
- W2670503891 cites W2049519621 @default.
- W2670503891 cites W2053558881 @default.
- W2670503891 cites W2058657335 @default.
- W2670503891 cites W2058782486 @default.
- W2670503891 cites W2067177007 @default.
- W2670503891 cites W2069084149 @default.
- W2670503891 cites W2069358402 @default.
- W2670503891 cites W2071573411 @default.
- W2670503891 cites W2081114661 @default.
- W2670503891 cites W2093706999 @default.
- W2670503891 cites W2095070107 @default.
- W2670503891 cites W2102216632 @default.
- W2670503891 cites W2106080983 @default.
- W2670503891 cites W2110029342 @default.
- W2670503891 cites W2111338104 @default.
- W2670503891 cites W2111824942 @default.
- W2670503891 cites W2115294629 @default.
- W2670503891 cites W2116934373 @default.
- W2670503891 cites W2125833216 @default.
- W2670503891 cites W2134439652 @default.
- W2670503891 cites W2142686356 @default.
- W2670503891 cites W2143506157 @default.
- W2670503891 cites W2152568605 @default.
- W2670503891 cites W2156796676 @default.
- W2670503891 cites W2160104144 @default.
- W2670503891 cites W2162101845 @default.
- W2670503891 cites W2171193387 @default.
- W2670503891 cites W2172120725 @default.
- W2670503891 cites W2178979521 @default.
- W2670503891 cites W2282369083 @default.
- W2670503891 cites W4239153876 @default.
- W2670503891 doi "https://doi.org/10.1371/journal.pone.0179156" @default.
- W2670503891 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5484485" @default.
- W2670503891 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/28650956" @default.
- W2670503891 hasPublicationYear "2017" @default.
- W2670503891 type Work @default.
- W2670503891 sameAs 2670503891 @default.
- W2670503891 citedByCount "18" @default.
- W2670503891 countsByYear W26705038912017 @default.
- W2670503891 countsByYear W26705038912018 @default.
- W2670503891 countsByYear W26705038912019 @default.
- W2670503891 countsByYear W26705038912020 @default.
- W2670503891 countsByYear W26705038912021 @default.
- W2670503891 countsByYear W26705038912022 @default.
- W2670503891 countsByYear W26705038912023 @default.
- W2670503891 crossrefType "journal-article" @default.
- W2670503891 hasAuthorship W2670503891A5002342549 @default.
- W2670503891 hasAuthorship W2670503891A5015876453 @default.
- W2670503891 hasAuthorship W2670503891A5016039667 @default.
- W2670503891 hasAuthorship W2670503891A5045206039 @default.
- W2670503891 hasAuthorship W2670503891A5047483416 @default.
- W2670503891 hasAuthorship W2670503891A5051385271 @default.
- W2670503891 hasAuthorship W2670503891A5056031868 @default.
- W2670503891 hasAuthorship W2670503891A5057713605 @default.
- W2670503891 hasAuthorship W2670503891A5071985251 @default.
- W2670503891 hasAuthorship W2670503891A5075153538 @default.
- W2670503891 hasAuthorship W2670503891A5078949048 @default.
- W2670503891 hasBestOaLocation W26705038911 @default.
- W2670503891 hasConcept C126322002 @default.
- W2670503891 hasConcept C134018914 @default.
- W2670503891 hasConcept C150903083 @default.
- W2670503891 hasConcept C170493617 @default.
- W2670503891 hasConcept C202751555 @default.
- W2670503891 hasConcept C207001950 @default.
- W2670503891 hasConcept C2776808119 @default.
- W2670503891 hasConcept C2778024521 @default.
- W2670503891 hasConcept C2779306644 @default.